Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

896 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.
Tubach F, Salmon D, Ravaud P, Allanore Y, Goupille P, Bréban M, Pallot-Prades B, Pouplin S, Sacchi A, Chichemanian RM, Bretagne S, Emilie D, Lemann M, Lortholary O, Mariette X; Research Axed on Tolerance of Biotherapies Group. Tubach F, et al. Among authors: lortholary o. Arthritis Rheum. 2009 Jul;60(7):1884-94. doi: 10.1002/art.24632. Arthritis Rheum. 2009. PMID: 19565495 Free PMC article.
Long-term follow-up of patients with tuberculosis as a complication of tumour necrosis factor (TNF)-alpha antagonist therapy: safe re-initiation of TNF-alpha blockers after appropriate anti-tuberculous treatment.
Denis B, Lefort A, Flipo RM, Tubach F, Lemann M, Ravaud P, Salmon D, Mariette X, Lortholary O; RATIO Group. Denis B, et al. Among authors: lortholary o. Clin Microbiol Infect. 2008 Feb;14(2):183-6. doi: 10.1111/j.1469-0691.2007.01891.x. Epub 2007 Dec 10. Clin Microbiol Infect. 2008. PMID: 18076664 Free article.
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry.
Salmon-Ceron D, Tubach F, Lortholary O, Chosidow O, Bretagne S, Nicolas N, Cuillerier E, Fautrel B, Michelet C, Morel J, Puéchal X, Wendling D, Lemann M, Ravaud P, Mariette X; RATIO group. Salmon-Ceron D, et al. Among authors: lortholary o. Ann Rheum Dis. 2011 Apr;70(4):616-23. doi: 10.1136/ard.2010.137422. Epub 2010 Dec 21. Ann Rheum Dis. 2011. PMID: 21177290
Emergence of Legionella pneumophila pneumonia in patients receiving tumor necrosis factor-alpha antagonists.
Tubach F, Ravaud P, Salmon-Céron D, Petitpain N, Brocq O, Grados F, Guillaume JC, Leport J, Roudaut A, Solau-Gervais E, Lemann M, Mariette X, Lortholary O; Recherce Axée sur la Tolérance des Biothérapies Group. Tubach F, et al. Among authors: lortholary o. Clin Infect Dis. 2006 Nov 15;43(10):e95-100. doi: 10.1086/508538. Epub 2006 Oct 16. Clin Infect Dis. 2006. PMID: 17051484 Clinical Trial.
The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region.
Mariette X, Vencovsky J, Lortholary O, Gomez-Reino J, de Longueville M, Ralston P, Weinblatt M, van Vollenhoven R. Mariette X, et al. Among authors: lortholary o. RMD Open. 2015 Apr 28;1(1):e000044. doi: 10.1136/rmdopen-2014-000044. eCollection 2015. RMD Open. 2015. PMID: 26509064 Free PMC article.
Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
Gottenberg JE, Guillevin L, Lambotte O, Combe B, Allanore Y, Cantagrel A, Larroche C, Soubrier M, Bouillet L, Dougados M, Fain O, Farge D, Kyndt X, Lortholary O, Masson C, Moura B, Remy P, Thomas T, Wendling D, Anaya JM, Sibilia J, Mariette X; Club Rheumatismes et Inflammation (CRI). Gottenberg JE, et al. Among authors: lortholary o. Ann Rheum Dis. 2005 Jun;64(6):913-20. doi: 10.1136/ard.2004.029694. Epub 2004 Nov 18. Ann Rheum Dis. 2005. PMID: 15550531 Free PMC article.
Temporal artery biopsy: a diagnostic tool for systemic necrotizing vasculitis. French Vasculitis Study Group.
Généreau T, Lortholary O, Pottier MA, Michon-Pasturel U, Ponge T, de Wazières B, Liozon E, Pinède L, Hachulla E, Roblot P, Barrier JH, Herson S, Guillevin L. Généreau T, et al. Among authors: lortholary o. Arthritis Rheum. 1999 Dec;42(12):2674-81. doi: 10.1002/1529-0131(199912)42:12<2674::AID-ANR25>3.0.CO;2-A. Arthritis Rheum. 1999. PMID: 10616017 Free article.
Corticosteroids plus pulse cyclophosphamide and plasma exchanges versus corticosteroids plus pulse cyclophosphamide alone in the treatment of polyarteritis nodosa and Churg-Strauss syndrome patients with factors predicting poor prognosis. A prospective, randomized trial in sixty-two patients.
Guillevin L, Lhote F, Cohen P, Jarrousse B, Lortholary O, Généreau T, Léon A, Bussel A. Guillevin L, et al. Among authors: lortholary o. Arthritis Rheum. 1995 Nov;38(11):1638-45. doi: 10.1002/art.1780381116. Arthritis Rheum. 1995. PMID: 7488285 Clinical Trial.
896 results